Log In
BCIQ
Print this Print this
 

MLR-1023

  Manage Alerts
Collapse Summary General Information
Company Melior Discovery Inc.
DescriptionLyn kinase (LYN) activator
Molecular Target Lyn kinase (LYN)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
PartnerBukwang Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/16/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today